Search Results 911-920 of 14642 for anti-TNF drugs
Immune checkpoint inhibitor (ICI) drugs have revolutionized cancer therapy ... He started a combination immunotherapy of ipilimumab (anti-CTLA-4) and nivolumab ( ...
... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alesse; Alesse-28; Altavera; Amethia ...
... anti-PD-1 antibody blockade enhances anti-tumor activity in glioblastoma treatment; Demonstrating that intraperitoneal administration of measles virus-sodium ...
Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Serdexmethylphenidate and dexmethylphenidate combination is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines ...
Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Patients who were previously exposed to tumor necrosis factor (TNF) ...
Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...
Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.